Chemoinformaics analysis of 1-Allyl-2,3,4,5-Tetramethoxybenzene
| Molecular Weight | 238.283 | nRot | 6 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 7 |
| Exact Molecular Weight | 238.121 | nRing | 1 |
| Solubility: LogS | -2.542 | nHRing | 0 |
| Solubility: LogP | 2.323 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 36.9203 |
| nHD | 0 | BPOL | 25.0017 |
| QED | 0.713 |
| Synth | 2.178 |
| Natural Product Likeliness | 0.597 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.099 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.482 |
| MDCK | 0.0000194 |
| BBB | 0.544 |
| PPB | 0.806435 |
| VDSS | 0.846 |
| FU | 0.128217 |
| CYP1A2-inh | 0.775 |
| CYP1A2-sub | 0.973 |
| CYP2c19-inh | 0.481 |
| CYP2c19-sub | 0.923 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.035 |
| CYP2d6-sub | 0.916 |
| CYP3a4-inh | 0.269 |
| CYP3a4-sub | 0.706 |
| CL | 7.686 |
| T12 | 0.717 |
| hERG | 0.091 |
| Ames | 0.06 |
| ROA | 0.097 |
| SkinSen | 0.874 |
| Carcinogencity | 0.391 |
| EI | 0.731 |
| Respiratory | 0.051 |
| NR-Aromatase | 0.593 |
| Antiviral | Yes |
| Prediction | 0.752588 |